NEWPORT BEACH, Calif., March 18, 2024 (GLOBE NEWSWIRE) - PIMCO, a global leader in active fixed income with deep expertise across public and private markets, is pleased to share the promotion of the officers of the firm to Managing Director.
"Embodying PIMCO’s core values while exhibiting integrity and excellence are qualities we look for in our Managing Director group. Our goal is to have a diverse set of talent that will make a positive impact for our clients’ investments, our firm, and the next generation of talent,” said PIMCO Chief Executive Officer Emmanuel Roman and PIMCO Group Chief Investment Officer Daniel Ivascyn.
The following officers have been promoted to Managing Director with these objectives in mind:
Masoud Sharif
Mr. Sharif is a managing director and Co-Head of PM Analytics in the Newport Beach office. Prior to joining PIMCO in 2011, he was a vice president in quantitative analytics at Barclays Capital. Mr. Sharif was previously an assistant professor in the electrical and computer engineering department at Boston University. He has 17 years of investment experience and holds a Ph.D. in electrical engineering from California Institute of Technology.
Marco van Akkeren
Mr. van Akkeren is a managing director and Co-Head of PM Analytics in the Newport Beach office. Prior to joining PIMCO in 2008, he worked in fixed income strategies at Goldman Sachs and at Morgan Stanley in New York. He has 23 years of investment experience and holds a Ph.D. in economics from the University of California, Berkeley, where he earned a master’s degree in statistics and an undergraduate degree.
Nick Mosich
Mr. Mosich is a managing director and deputy general counsel in the Newport Beach office. He is PIMCO’s head of alternatives legal. Prior to joining PIMCO in 2013, he was a senior associate with Latham & Watkins LLP, focusing on M&A, capital markets and general corporate matters. Prior to that, he clerked for a judge on the United States Court of Appeals for the 10th Circuit. He has 17 years of legal experience and holds a J.D. from the University of Southern California Gould School of Law, and an undergraduate degree from the University of Southern California Marshall School of Business. Mr. Mosich is a member of the California Bar.
DISCLOSURES
About PIMCO
PIMCO is a global leader in active fixed income with deep expertise across public and private markets. We invest our clients’ capital across a range of fixed income and credit opportunities, drawing upon our decades of experience navigating complex debt markets. Our flexible capital base and deep relationships with issuers have helped us become one of the world’s largest providers of traditional and nontraditional solutions for companies that need financing and investors who seek strong risk-adjusted returns.
Except for the historical information and discussions contained herein, statements contained in this news release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, including the performance of financial markets, the investment performance of PIMCO's sponsored investment products and separately managed accounts, general economic conditions, future acquisitions, competitive conditions and government regulations, including changes in tax laws. Readers should carefully consider such factors. Further, such forward-looking statements speak only on the date at which such statements are made. PIMCO undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.
Contact:
Michael Reid
Global Head of Corporate Communications
Ph. 212-597-1301
Email: michael.reid@pimco.com
-
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cVANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a di2024-06-17
-
Indonesia Stock Exchange Partners with Nasdaq to Upgrade Market InfrastructureTechnology partnership will further enhance overall resilience and integrity of the exchange, while supporting the rapid deployment of new products2024-06-17
-
Adalvo 的 Liraglutide 預充式注射筆成為歐盟首款獲得批准的仿製藥馬爾他聖瓜安, June 17, 2024 (GLOBE NEWSWIRE) -- Adalvo 宣布 Liraglutide 預充式注射筆成功取得 DCP 批准,成為歐盟首款獲得批准的仿製藥。 根據 IQVIA 的報2024-06-17
-
促进生育,助力三胎——“三胎免费生”联合公益行动正式启动为积极响应国家号召实施三胎生育政策,扩大妇幼服务健康供给,在云南省优生优育妇幼保健协会指导下,昆明广播电视台联合昆明安琪儿妇产医院,于6月13日在昆明广播2024-06-17
-
学党史传承红色精神 守党纪筑牢自律防线——平安养老险湖南分公司党支部开展主题党日活动七一前夕,平安养老险湖南分公司党支部全体成员走进“千年学府、百年师范”——湖南第一师范,开展了一次学史明理、学史增信、学史崇德、学史力行的主题党日活动。重2024-06-17